Miyako Capital
Venture capitalKyoto · Pre-Seed–Growth · 5 people tracked
Also known as みやこキャピタル株式会社
Investment thesis
As an independent private venture capital firm, Miyako Capital invests in technology-development startups that harness the advanced intellectual assets of academia and research institutions, with Kyoto University at its core. The firm serves as a designated collaborative fund operator for Kyoto University. Beyond capital, it supports portfolio growth through industry-academia collaboration that helps translate technology into real-world social implementation. Its aim is to cultivate the next generation of leading industries and innovation, with particular strength and investment focus in the life sciences and biotech domains, including drug discovery and medical devices.
Source: firm website, verified Aug 7, 2026.
Team · 5 people
from the firm's websiteWhat they invest in
from 31 of 44 portfolio companiesDeep Tech ×9Hardware ×9AI & Machine Learning ×8Biotech ×8Medical Devices ×7Cleantech ×5Healthtech ×4Digital Health ×3
HQs:Japan×24United States×3United Kingdom×1
Investments · 44 tracked
founders shown can be your intro pathLINK-US Co., Ltd. develops, designs, and manufactures devices based on ultrasonic complex vibration and high-power ultrasonic technology, including room-temperature bonding equipment for joining same and dissimilar metal materials.
Advanced ManufacturingDeep TechHardwareTokyo, JP
Jun Mitsuyuki(Representative Director)
Drivemode builds vehicle companion apps and in-vehicle software platforms for Honda and Acura cars and electric motorcycles, including connected apps like Honda RoadSync and the Drivemode Android app.
IoTMobility & TransportationSaaSSan Jose, US
Yokichi Koga(Executive Officer, Director)Yo Koga(CEO)
EX-Fusion is a Japanese private company developing laser-based nuclear fusion energy technology, aiming to decarbonize existing energy sources and contribute to carbon neutrality.
CleantechDeep TechEnergyKyoto, JP
Kazuki Matsuo(代表取締役社長 (President & CEO))
Galderia develops technology based on extremophile microalgae, including algae-derived bioadsorbents used for recovering trace metals such as palladium.
BiotechCircular EconomyCleantech
Tanimoto(Representative)
Goryo Chemical develops fluorescence-based technology to visualize diseases and support diagnosis and treatment.
BiotechHealthtechMedical DevicesNew MaterialsTokyo, JP
Hephas Energy develops environmentally friendly technologies and digital transformation tools aimed at supporting smart city initiatives and sustainable development.
CleantechClimate TechEnergy
IGS (Institution for a Global Society) provides AI-powered assessment tools that measure competencies, temperament, and non-cognitive skills of employees, job candidates, and students, visualizing capabilities for companies and educational institutions.
AI & Machine LearningEdTechHR Tech
IGS is a deep tech company that develops mathematical visualization technology based on solving the inverse problem of wave scattering, enabling it to see through objects by observing and analyzing electromagnetic waves scattered inside them.
Deep TechHardware
iHeart Japan is a regenerative medicine company developing cell-therapy products for the heart using iPS (induced pluripotent stem) cells, aiming to provide new treatment options for heart disease.
BiotechLongevityMedical Devices
Liqid builds a composable infrastructure platform that disaggregates data center hardware, letting IT teams dynamically compose and scale resources to improve performance, optimization, and footprint efficiency.
Cloud ComputingData & InfrastructureEnterprise SoftwareHardwareWestminster, US
Jim Antes(Executive Officer)Bryan Schramm(Executive Officer)Edgar Masri(Executive Officer, Director)Farbod Michael Ramm(Director)Jason Breakstone(Executive Officer, Director)
BoardRyan Pollock(Director)
LocationMind provides location intelligence and spatial analysis services using GNSS positioning, satellite imagery, IoT sensing (LiDAR, UWB), and mobile big data to support urban planning, infrastructure, mobility, and commercial applications across multiple sectors.
AI & Machine LearningData & InfrastructureIoTTokyo, JP
Naoki Kiritani(Founder / CEO)Ryosuke Shibasaki(Founder / CTO)Dinesh Manandhar(Founder / CDO)
Megakaryon is a Japanese regenerative-medicine venture developing platelet products derived from human iPS cells, including HLA-homozygous iPS-cell-derived platelets (MEG-002) that have advanced into clinical trials.
BiotechLongevityMedical Devices
Peds3 (Pediatrics 3.0) is a "kids DoTank" focused on the future of pediatric medicine, aiming to implement biopsychosocial care for children using digital tools and evidence.
Digital HealthHealthtech
Pocketalk makes an AI-powered handheld translation device for one-on-one conversations and "Sentio," an AI simultaneous interpretation service for one-to-many real-time interpreting across events, schools, retail, and government settings.
AI & Machine LearningEdTechHardware
Sakana AI develops frontier AI research and products, including large language models, multi-agent orchestration systems, and AI solutions tailored for Japanese enterprises and public sector organizations.
AI & Machine LearningDeep TechDefense TechTokyo, JP
David Ha(Co-Founder & CEO)Ren Ito(Co-Founder & Chairman)Llion Jones(Co-Founder & CTO)
SocialGood offers a shopping cash-back service and browser extension covering over 20,000 stores, where users earn rewards in the platform's SG cryptocurrency.
ConsumerCrypto & Web3E-commerce
UltraSolar Technology develops QuantumBoost (QB), a hardware device that increases the power output of photovoltaic modules by over 10% and lowers the levelized cost of energy for solar farm owners and operators.
CleantechEnergyHardwareSanta Clara, US
Ysunesaburo Sugaya(Director)Santosh Kumar(Executive Officer, Director)Rob Soni(Director)Rahul Chopra(Director)
Varinos develops and provides genetic testing services applying genome technology, including a uterine microbiome (endometrial flora) test used in fertility and reproductive medicine.
BiotechDigital HealthFemTechMedical DevicesTokyo, JP
桜庭 喜行(Founder & Chairman (former CEO))長井 陽子(Co-founder)齊藤 洋一(代表取締役CEO)平川 秀年(代表取締役社長)Sakuraba(CEO)
VividQ develops computer-generated holography (CGH) software and technology for 3D holographic displays, with an early focus on AR and VR gaming applications.
Deep TechGamingHardware
Startbahn provides Startrail, a blockchain-based platform for the art market that records the provenance, authenticity, and ownership history of artworks, using NFC tags and NFTs to verify pieces and enable resale royalties for creators.
Crypto & Web3Media & EntertainmentSaaS
Sukutachi is a mobile app that connects construction businesses and craftspeople to discover work opportunities and expand their professional networks.
Construction TechMarketplaces
Innovative Space Carrier (将来宇宙輸送システム株式会社) is a Japanese company developing future space transportation systems.
Deep TechHardwareLogistics & Supply ChainSpace TechTokyo, JP
畑田 (Hatakuta)(CEO)野村 (Nomura)(COO)畑田 康二郎(代表取締役社長 兼 最高経営責任者 (CEO))
FLOSFIA develops power semiconductor devices based on corundum-structure gallium oxide (α-Ga₂O₃), a material originating from Kyoto University in Japan, using its proprietary water-based "MISTEPITAXY" mist deposition process to achieve lower loss than SiC at silicon-level cost.
CleantechDeep TechNew MaterialsSemiconductorsKyoto, JP
四戸孝(代表取締役社長 (President & CEO))人羅俊実(創業者・取締役会長 (Founder & Chairman))
Ai-BrainScience Inc. is a Japanese company holding a Type 2 medical device manufacturing and sales license.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSuita, JP
森下 竜一(取締役会長 (Chairman))髙村 健太郎(代表取締役社長 (President & CEO))北嶋 学(取締役 (Director))
StemRIM is a biopharmaceutical company developing regenerative medicine therapies.
BiotechHealthtechMedical Devices
Kyoto Drug develops novel therapeutic drugs for rare and difficult-to-treat ocular diseases including retinal artery occlusion and retinitis pigmentosa, using a new small-molecule compound (KUS agent) based on research from Kyoto University.
BiotechMedical DevicesKyoto, JP
Musashi (武蔵)(CEO)
Portfolio news
latest coverage across their companiesSakana AI · techcrunch.com · Nov 17, 2025
Frequently asked questions
- What stage does Miyako Capital invest at?
- Miyako Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Miyako Capital focus on?
- Miyako Capital focuses on Biotech, Deep Tech, Energy, Healthtech, Medical Devices, Sector Agnostic.
- Where is Miyako Capital located?
- Miyako Capital is headquartered in Kyoto, JP.
Images
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Innovestor is a Nordic investment group operating across venture capital, life science, real estate, energy storage, and corporate venturing platforms, and is among the most active early-stage investors in the region.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
UTEC is a venture capital firm that invests in seed and early-stage technology companies and is affiliated with the University of Tokyo.